Pan-cancer analysis of PSCA that is associated with immune infiltration and affects patient prognosis
PLOS ONE · 25.06.2024 · 19 (6) · e0298469
DOI: 10.1371/journal.pone.0298469 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 25.06.2024. Verfasst von Chenxing Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Affiliated Hospital of Nantong University, Medical school of Nantong University, Nantong, China. Hauptthemen laut MEDLINE: Antigens, Neoplasm, Tumor Microenvironment, Lymphocytes, Tumor-Infiltrating, Neoplasm Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Project of Nantong City.
Abstract (Originalsprache)
Prostate stem cell antigen (PSCA) is associated with disease progression, promotion of angiogenesis, invasion, metastasis and immune evasion in cancer. However, its expression pattern and diagnostic and prognostic potential have not been thoroughly analysed from a pan-cancer perspective. This study aimed to examine the effects of PSCA on the prognosis and inflammatory cell infiltration patterns of various cancer types. We analysed the relationship between PSCA expression and immunological subtypes in tumor microenvironment (TME) and the role of molecular subtypes, potentially promising immune biomarkers and tumour-infiltrating lymphocytes (TILs) in various cancer types, especially lung adenocarcinoma (LUAD). In addition, we investigated the prognostic significance of PSCA expression in LUAD. The co-expression network of PSCA was found to be mainly involved in the regulation of immune responses and antigen processing and expression and was significantly enriched in pathological and substance metabolism-related pathways in cancer. Altogether, this study reveals that PSCA is a promising target for immunotherapy in patients with cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Affiliated Hospital of Nantong University, Medical school of Nantong University, Nantong, China.
- Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China.
- Department of Laboratory Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China.
- Eye Institute, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu, China.
- Department of Clinical Biobank & Institute of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China.
- Department of Trauma Center, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China.
ORCID-Profile: Ziheng Wang, Yang Yang
Förderung
- Science and Technology Project of Nantong City
Zitieren
APA
Wang, C., Zhu, X., Zheng, M., Chen, Y., Jiang, R., He, X., Liu, Z., Lu, Z., Wang, Z., & Yang, Y. (2024). Pan-cancer analysis of PSCA that is associated with immune infiltration and affects patient prognosis. PLOS ONE, 19(6), e0298469. https://doi.org/10.1371/journal.pone.0298469
Vancouver
Wang C, Zhu X, Zheng M, Chen Y, Jiang R, He X, et al. Pan-cancer analysis of PSCA that is associated with immune infiltration and affects patient prognosis. PLOS ONE. 2024;19(6):e0298469. doi:10.1371/journal.pone.0298469
BibTeX
@article{Wang2024,
author = {Wang, Chenxing and Zhu, Xingjia and Zheng, Ming and Chen, Yixun and Jiang, Rui and He, Xinyi and Liu, Zongheng and Lu, Zhichao and Wang, Ziheng and Yang, Yang},
title = {Pan-cancer analysis of PSCA that is associated with immune infiltration and affects patient prognosis},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {6},
pages = {e0298469},
doi = {10.1371/journal.pone.0298469}
}
EUVIMED